ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 627988 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 627988; 2) Community: the network communities that were significantly associated with the response to NSC 627988; 3) Molecule: the relationships between components within communities and NSC 627988; 4) MDR: the compounds that were significantly associated with the NSC 627988.

NSC Compound Enrichment Correlation
NSC 113497 16,17-Seco-24-nor-5.alpha.,13.alpha.,14.beta.,17.alpha.-chola-1,20,22-trien-16-oic acid, 14,15.beta.:21,23-diepoxy-7.alpha.,17-dihydroxy-4,4,8-trimethyl-3-oxo-, 16,17-lactone, acetate (8CI) 0.0135588245836371 0.35640852
NSC 129790 Null 0.0135588245836371 0.082908384
NSC 173552 L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate 0.0135588245836371 0.34315685
NSC 18805 .gamma.-Thujaplicine 0.0135588245836371 0.28263055
NSC 23925 Null 0.0135588245836371 0.060170449
NSC 244404 Null 0.0135588245836371 0.37024423
NSC 300289 Pinafide 0.0135588245836371 0.20852895
NSC 33570 Null 0.0135588245836371 0.26087463
NSC 349622 Cytovaricin 0.0135588245836371 0.015212042
NSC 372155 2-Propenamide, N-[(cyanoamino)iminomethyl]-2-methyl- 0.0135588245836371 -0.042177854
Total:123  Current:29    [First] [Prev] [Next] [Last]